MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

How do cognitive profiles differ in patients with Parkinson’s disease with cognitive decline in comparison to patients remaining cognitively stable? Preliminary results of a 3 years follow-up study

A. Meyer, U. Gschwandtner, V. Cozac, F. Hatz, P. Fuhr (Basel, Switzerland)

Meeting: 2016 International Congress

Abstract Number: 1448

Keywords: Cognitive dysfunction, Dementia, Parkinsonism

Session Information

Date: Wednesday, June 22, 2016

Session Title: Parkinson's disease: Cognition

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: (1) To ascertain the evolution of neuropsychological profile of PD patients with stable cognition (non-converter) in comparison to PD patients with a decline (converters) over three years. (2) To characterize the predictive influence of sample characteristics (including age, gender, education, disease duration, MMSE, severity of motor symptoms), depression, apathy and IQCODE (informant questionnaire on cognitive decline) at baseline.

Background: Cognitive alterations are common in PD even at early stages, and they progress in up to 90% to PD dementia (PDD) at late stages. The speed of cognitive decline varies and may be influenced by sample characteristics, affective disorders and by extent and type of neuropsychological deficits.

Methods: Fifty-three non demented PD patients underwent neuropsychological and neurological examination and completed questionnaires (apathy, depression) at baseline (T0). A relative filled out the IQCODE. In the still ongoing study, 31 (10f) patients have been revaluated after 3 years (T1). Diagnosis of PD-MCI and PDD was made according to current recommendations by the Movement Disorders Society.

Results: PD-MCI occurred in 16/53 patients at T0. At T1, 22 had remained stable (17 cognitively intact; 5 remaining in MCI) and 8 had converted either to MCI or PDD (5 converted to PDD, 3 converted to MCI); 1 patient had reverted to normal cognition. At baseline, the converters were significantly older (p < .05), had more severe motor signs (p < .05) and lower cognitive scores in all domains, especially in aspects of executive functions and in the memory domain (see figure 1 & 2). The IQCODE indicated a clinically relevant cognitive decline (mean = 3.36), whereas it was below the clinical cut off in the non-converter group (mean = 3.07). No significant differences were found in severity of depression, apathy.

Conclusions: In our sample more severe cognitive and motor impairment as well as older age at T0 were associated with cognitive decline after T1; particularly impairments in memory and executive function domains were related to further cognitive decline. However, severity of depression or apathy at T0 did not differ between converters and non-converters.

To cite this abstract in AMA style:

A. Meyer, U. Gschwandtner, V. Cozac, F. Hatz, P. Fuhr. How do cognitive profiles differ in patients with Parkinson’s disease with cognitive decline in comparison to patients remaining cognitively stable? Preliminary results of a 3 years follow-up study [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/how-do-cognitive-profiles-differ-in-patients-with-parkinsons-disease-with-cognitive-decline-in-comparison-to-patients-remaining-cognitively-stable-preliminary-results-of-a-3-years-follow-up-study/. Accessed May 24, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/how-do-cognitive-profiles-differ-in-patients-with-parkinsons-disease-with-cognitive-decline-in-comparison-to-patients-remaining-cognitively-stable-preliminary-results-of-a-3-years-follow-up-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley